{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:44:07Z","timestamp":1788929047417,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"DOI":"10.7759\/cureus.53444","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T09:24:46Z","timestamp":1706865886000},"source":"Crossref","is-referenced-by-count":4,"title":["A Case of Tizanidine Withdrawal and Road to Recovery"],"prefix":"10.7759","author":[{"given":"Tomas","family":"Escobar Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin  J","family":"McGeorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.0090s1030.x","article-title":"The medical management of spasticity","volume":"9","author":"Abbruzzese G","year":"2002","unstructured":"Abbruzzese G. The medical management of spasticity. Eur J Neurol. 2002, 9:30-34. 10.1046\/j.1468-1331.2002.0090s1030.x","journal-title":"Eur J Neurol"},{"key":"ref2","unstructured":"MEPS-HC Data Tools - Medical Expenditure Panel Survey (MEPS) Household Component (HC). (2024). Accessed. January 8, 2024: https:\/\/datatools.ahrq.gov\/meps-hc\/?tab=prescribed-drugs&dash=18."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49248","article-title":"A case of tizanidine withdrawal syndrome: features and management in the emergency department","volume":"15","author":"Morgom M","year":"2023","unstructured":"Morgom M, Sabir DM, Elbashir H, Saeed L, Alamin A, Abuazab Y, Abdelrahman N. A case of tizanidine withdrawal syndrome: features and management in the emergency department. Cureus. 2023, 15:e49248. 10.7759\/cureus.49248","journal-title":"Cureus"},{"key":"ref4","article-title":"Dependencia a los relajantes musculares- Tizanidina: reporte de un caso [Spanish]","volume":"46","author":"Suelt MJ","year":"2021","unstructured":"Suelt MJ, Arcila JE. Dependencia a los relajantes musculares- Tizanidina: reporte de un caso [Spanish]. Revista espan\u0303ola de drogodependencias. 2021, 46:95-100.","journal-title":"Revista espan\u0303ola de drogodependencias"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A1568","article-title":"Tizanidine withdrawal syndrome: a case report","volume":"205","author":"Perez OA","year":"2022","unstructured":"Perez OA, Tauquir A, Janosko J, Saleem T, Sarin K. Tizanidine withdrawal syndrome: a case report. Am J Respir Crit Care Med. 2022, 205:1568. 10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A1568","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1399167","article-title":"Tizanidine withdrawal symptoms in stress cardiomyopathy [German]","volume":"83","author":"M\u00f6rkl S","year":"2015","unstructured":"M\u00f6rkl S, Bengesser SA, Sch\u00f6ggl H, Bayer D, Kapfhammer HP. Tizanidine withdrawal symptoms in stress cardiomyopathy [German]. Fortschr Neurol Psychiatr. 2015, 83:170-3. 10.1055\/s-0034-1399167","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2020.1738574","article-title":"Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform pain disorder","volume":"25","author":"Kitta A","year":"2020","unstructured":"Kitta A, Wippel A, Richwien P, et al.. Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform pain disorder. J Subst Use. 2020, 25:535-7. 10.1080\/14659891.2020.1738574","journal-title":"J Subst Use"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.10.003","article-title":"A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature","volume":"33","author":"Karol DE","year":"2011","unstructured":"Karol DE, Muzyk AJ, Preud'homme XA. A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature. Gen Hosp Psychiatry. 2011, 33:84.e1-2. 10.1016\/j.genhosppsych.2010.10.003","journal-title":"Gen Hosp Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-022-01356-1","article-title":"Management of tizanidine abuse and withdrawal in a 53-year-old woman: a case report","volume":"5","author":"Daniels NF","year":"2023","unstructured":"Daniels NF, Ridwan R, Vasileva AMD. Management of tizanidine abuse and withdrawal in a 53-year-old woman: a case report. SN Compr Clin Med. 2023, 5:1-4. 10.1007\/s42399-022-01356-1","journal-title":"SN Compr Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1081\/clt-200026978","article-title":"Retrospective review of Tizanidine (Zanaflex) overdose","volume":"42","author":"Spiller HA","year":"2004","unstructured":"Spiller HA, Bosse GM, Adamson LA. Retrospective review of Tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol. 2004, 42:593-6. 10.1081\/clt-200026978","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref11","unstructured":"Tizanidine; the lethal withdrawal. (2022). Accessed. January 8, 2024: https:\/\/www.researchgate.net\/publication\/372910111_Tizanidine_The_Lethal_Withdrawal."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-014-0430-3","article-title":"Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?","volume":"10","author":"Albertson TE","year":"2014","unstructured":"Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?. J Med Toxicol. 2014, 10:369-81. 10.1007\/s13181-014-0430-3","journal-title":"J Med Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.59.457","article-title":"Tizanidine may discriminate between imidazoline-receptors and alpha 2-adrenoceptors","volume":"59","author":"Muramatsu I","year":"1992","unstructured":"Muramatsu I, Kigoshi S. Tizanidine may discriminate between imidazoline-receptors and alpha 2-adrenoceptors. Jpn J Pharmacol. 1992, 59:457-9. 10.1254\/jjp.59.457","journal-title":"Jpn J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000955","article-title":"Management of xylazine withdrawal in a hospitalized patient: a case report","volume":"16","author":"Ehrman-Dupre R","year":"2022","unstructured":"Ehrman-Dupre R, Kaigh C, Salzman M, Haroz R, Peterson LK, Schmidt R. Management of xylazine withdrawal in a hospitalized patient: a case report. J Addict Med. 2022, 16:595-8. 10.1097\/ADM.0000000000000955","journal-title":"J Addict Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226846-a-case-of-tizanidine-withdrawal-and-road-to-recovery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:17:41Z","timestamp":1707491861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226846-a-case-of-tizanidine-withdrawal-and-road-to-recovery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.53444","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}